Acute psychosis following sustained release bupropion overdose.
Bupropion is an antidepressant that is structurally related to amphetamines and enhances dopamine neurotransmission through inhibiting neuronal dopamine re-uptake. Bupropion-related psychosis has been recognized in several papers, but these reports of bupropion-related psychosis almost all involve immediate release (IR) formulation. We present a case of acute psychosis following sustained release bupropion (SR) overdose. A 23-year-old male was admitted because of major depression and a suicidal attempt by ingesting 28 tablets of 150 mg bupropion SR and 14 tablets of 7.5 mg midazolam. He developed paranoid delusions 12 h after the bupropion SR overdose. The paranoid symptoms remitted on the third day of his admission. Our case of acute psychosis following bupropion SR overdose indicates the importance of being aware of the rare complication in patients receiving bupropion SR treatment.
Wang
Tzong-Shi
TS
Department of Psychiatry, Tri-Service General Hospital, No 325, Sec 2, Cheng-Kung RD, Neihu District, 114, Taipei, Taiwan.
Shiah
I-Shin
IS
Yeh
Chin-Bin
CB
Chang
Chuan-Chia
CC
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000506:poisoning*; D000931:Antidotes / Q000627:therapeutic use; D016642:Bupropion / Q000506:poisoning*; D002606:Charcoal / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D062787:Drug Overdose; D006801:Humans; D007508:Irritable Mood; D008297:Male; D011595:Psychomotor Agitation / Q000523:psychology; D011605:Psychoses, Substance-Induced / Q000523:psychology*; D013406:Suicide, Attempted / Q000523:psychology
D018687:Antidepressive Agents, Second-Generation; D000931:Antidotes; D003692:Delayed-Action Preparations; D016642:Bupropion; D002606:Charcoal